$3.19
-0.0127-0.4%
Last update: Oct 22, 12:04 AM
Immutep Ltd (IMMP) Stock Price, Quote, News & History
IMMPNASDAQ
Immutep stock jumps after FDA orphan drug tag for eftilagimod alfa, even as halted Phase 3 trial and mixed analyst views weigh on outlook.
You can purchase shares of Immutep (NASDAQ:IMMP) through any online brokerage.
Other companies in Immutep’s space includes: AbbVie Inc (NYSE:ABBV), Amgen Inc (NASDAQ:AMGN), Gilead Sciences Inc (NASDAQ:GILD), Vertex Pharmaceuticals Inc (NASDAQ:VRTX) and Regeneron Pharmaceuticals Inc (NASDAQ:REGN).
Immutep has a consensus price target of $140.00.
The stock price for Immutep (NASDAQ: IMMP) is $3.1873 last updated October 22, 2026 at 12:04 AM EDT.
There are no upcoming dividends for Immutep.
Immutep does not have any upcoming earnings scheduled.
There is no upcoming split for Immutep.
Immutep is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.
Immutep Ltd is a clinical-stage biotechnology company developing novel Lymphocyte Activation Gene-3 (LAG-3) related immunotherapies for cancer and autoimmune disease. It has a diversified product portfolio that harnesses LAG-3's ability to stimulate...
